首页> 外文期刊>Acta oncologica. >Loco-regional morbidity after breast conservation and axillary lymph node dissection for early breast cancer with or without regional nodes radiotherapy, perspectives in modern breast cancer treatment: the Skagen Trial 1 is active
【24h】

Loco-regional morbidity after breast conservation and axillary lymph node dissection for early breast cancer with or without regional nodes radiotherapy, perspectives in modern breast cancer treatment: the Skagen Trial 1 is active

机译:乳房保护和腋窝淋巴结解剖早期乳腺癌的基因群地区发病率或没有区域节点放射治疗,在现代乳腺癌治疗中的观点:Skagen试验1是活跃的

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Axillary lymph node dissection (ALND) and adjuvant radiotherapy (RT) in early breast cancer are associated with a risk of morbidity, including lymphedema and impaired shoulder mobility. The aim of this study was to evaluate loco-regional morbidity after breast conserving surgery (BCS), ALND, taxane-based chemotherapy and whole breast irradiation (WBI) with or without regional nodes RT.Material and methods: Eligible patients had BCS and ALND from 2007 to 2012 followed by adjuvant taxane-based chemotherapy and if indicated, trastuzumab and endocrine treatment. The RT consisted of WBI and regional nodes RT in case of pN1 disease (group 1) and WBI only in case of pN0-1(mic) disease (group 2). The dose was 50Gy in 25 fractions. The patients were invited to participate in a cross-sectional study evaluating morbidity.Results: Of the 347 eligible patients, 277 patients (79%) accepted the invitation. Of these, 185 patients (67%) belonged to group 1 and 92 patients (33%) to group 2. The median time from RT to evaluation of morbidity was 3.3 years (group 1) and 4.3 years (group 2). In group 1, 34 patients (18%) and in group 2, 15 patients (16%) had 2cm enlargement in circumference of ipsilateral upper or lower arm (p=.67). The frequence of impairment of ipsilateral shoulder abduction to 120 degrees was 3% in both groups and of shoulder flexion to 120 degrees was 1% and 2% (group 1 versus 2). No difference in patient reported outcome measure (PROM) data regarding heaviness or enlargement of ipsilateral upper and lower arm or mobility and sensory disturbances.Conclusion: The risk of lymphedema was low in patients after ALND and not related to use of regional nodes RT. Impairment of shoulder function was rare, and no differences in PROM were detected regarding use or not of regional nodes RT.
机译:背景:早期乳腺癌中的腋窝淋巴结解剖(ALND)和佐剂放射疗法(RT)与发病率的风险有关,包括淋巴米瘤和肩部流动性受损。本研究的目的是评估乳房保守手术(BCS),ALND,紫杉烷的化疗和全乳腺辐射(WBI)后的基因群地区发病率,或没有区域节点RT.Material和方法:符合条件的患者有BCS和ALND从2007年到2012年,其次是佐剂紫杉烷基化疗,如果指出,曲妥珠单抗和内分泌治疗。在PN1疾病(第1组)和WBI的情况下,RT由WBI和区域节点Rt组成,仅在PN0-1(MIC)疾病(第2组)。剂量在25分数中为50Gy。邀请患者参与评估发病率的横断面研究。结果:347个符合条件的患者,277名患者(79%)接受了邀请。其中185名患者(67%)属于1组和92名患者(33%)至第2组。从RT到发病率评估的中位时间为3.3岁(第1组)和4.3岁(第2组)。在第1组,34名患者(18%)和第2组中,15名患者(16%)在同侧上臂或下臂周长(P = 0.67)的圆周上具有2cm的增大。两组同侧肩部绑定到120度的频率为3%,肩部屈曲至120度为1%和2%(第1组与2组)。患者报告的结果衡量(PROM)关于沉重或扩大同侧上臂或移动性和感觉干扰的差异。结论:患者患者淋巴米肿瘤的风险低,与区域节点RT的使用无关。肩部功能的减值是罕见的,并且在区域节点RT中没有检测到PROM的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号